MedTrace Logo

Lactobacillus Reuteri DSM17938 in C-Section Infants

NCT03834415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2019-06-20

No results posted yet for this study

Summary

RCT designed to evaluate the impact of Lactobacillus reuteri DSM17938 to modify gut microbiota in children delivered by C-section

Conditions

  • C-section

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM17038

Oil drops of L. reuteri containing 1x10\>8 CFU

OTHER

Placebo for Probiotics

Oil drops mimicking in consistency and flavor to experimental product

Sponsors & Collaborators

  • BioGaia AB

    collaborator INDUSTRY

  • Innovacion y Desarrollo de Estrategias en Salud

    lead OTHER

Principal Investigators

  • Pedro Gutierrez Castrellon, MD, MSc, DSc · Hospital General Dr. Manuel Gea Gonzalez

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Hours
Max Age
36 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2019-04-18
Completion
2019-06-18

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834415 on ClinicalTrials.gov